← Leaderboards
Xiaohui Ni
Earlydiagnostics, Inc.
$1,016,503
Attributed
$2,346,216
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $997.3K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,346,216 · 2
By mechanism
R44$1,994,570 · 1
R43$351,646 · 1
Top collaborators
- Steven-Huy B Han2 shared
- Anna Sf Lok2 shared
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureMalignant Neoplasm Of LiverCost EffectiveEarly DiagnosisLibrariesLow Dose Computed TomographyClia CertifiedCohortCirrhosisDetectionLaboratoriesBlood SpecimenClinical PracticeLiquid BiopsyCancer DetectionBioinformaticsCancer PatientAutomationCancer SurvivalCancer TypeBisulfite SequencingCell Free DnaBloodMalignant Neoplasm Of Lung
Grant awards (3)
MethylScan for Early Detection of Liver and Lung Cancer$997,285
R44 · FY2023 · CA · contact PI
MethylScan for Early Detection of Liver and Lung Cancer$997,285
R44 · FY2022 · CA · contact PI
An Accurate, Non-invasive, and Cost-effective Methylome Test for Early Cancer Detection$351,646
R43 · FY2020 · CA · contact PI